Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

The Relationship of Sevoflurane Consumption With Metabolic Age

ID
Name
Inonu 2022/92
Description
The aim of this clinical study is to determine the consumption of sevoflurane, which is one of the inhalation anesthetics, with metabolic age and basal metabolic rate. The basal metabolic rates and metabolic ages of the patients who will be given sevoflurane- maintained general anesthesia were measured preoperatively. The relationship between the amount of sevoflurane consumption and the measured data of the patients in the postoperative period was examined.
Trial arms
Trial start
2022-09-09
Estimated PCD
2023-03-01
Trial end
2023-03-03
Status
Completed
Treatment
Sevoflurane Baxter, 100%, Inhalation Vapour, Liquid 250 mL
No procedure was performed on the patient other than routine anesthesia management.We compared sevoflurane consumption amount in the patient undergoing general anesthesia with sevoflurane according to their metabolic age.
Arms:
percent age difference -6.6% to 11.7% those between, percent age difference < -6.6%, percent age difference > 11.7%
Other names:
No procedure was performed on the patient other than routine anesthesia management.
Size
79
Primary endpoint
consumption of sevoflurane
patients during surgery
Eligibility criteria
Inclusion Criteria: Between the ages of 18-65 who are scheduled for rhinoplasty or septoplasty with ASA I-II Cases lasting 1 to 3 hours Exclude Criteria: Patients at high risk of malignant hyperthermia, with a history of allergy to general anesthesia or any of the drugs to be used in the study, accepted as ASA III- ASA IV
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'CASE_CONTROL', 'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'count': 79, 'type': 'ACTUAL'}}
Updated at
2023-08-30

1 organization

1 product

1 indication

Organization
Inonu University
Product
Sevoflurane Baxter
Indication
Sevoflurane